Literature DB >> 17434932

Toxoplasma gondii and schizophrenia: linkage through astrocyte-derived kynurenic acid?

Robert Schwarcz1, Christopher A Hunter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17434932      PMCID： PMC2526138          DOI： 10.1093/schbul/sbm030

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN： 0586-7614            Impact factor:   9.306


× No keyword cloud information.
  16 in total

Review 1.  The role of astrocytes in the immunopathogenesis of toxoplasmic encephalitis.

Authors:  Emma H Wilson; Christopher A Hunter
Journal:  Int J Parasitol       Date:  2004-04       Impact factor: 3.981

2.  Modulators of the kynurenine pathway of tryptophan metabolism: synthesis and preliminary biological evaluation of (S)-4-(ethylsulfonyl)benzoylalanine, a potent and selective kynurenine aminotransferase II (KAT II) inhibitor.

Authors:  Roberto Pellicciari; Rosa C Rizzo; Gabriele Costantino; Maura Marinozzi; Laura Amori; Paolo Guidetti; Hui-Qiu Wu; Robert Schwarcz
Journal:  ChemMedChem       Date:  2006-05       Impact factor: 3.466

3.  Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum.

Authors:  Arash Rassoulpour; Hui-Qiu Wu; Sergi Ferre; Robert Schwarcz
Journal:  J Neurochem       Date:  2005-05       Impact factor: 5.372

4.  Micromolar brain levels of kynurenic acid are associated with a disruption of auditory sensory gating in the rat.

Authors:  Paul D Shepard; Brian Joy; Lucy Clerkin; Robert Schwarcz
Journal:  Neuropsychopharmacology       Date:  2003-04-16       Impact factor: 7.853

5.  Anti-Toxoplasma gondii antibodies in patients with schizophrenia--preliminary findings in a Turkish sample.

Authors:  Zafer Cetinkaya; Suleyman Yazar; Omer Gecici; Mustafa N Namli
Journal:  Schizophr Bull       Date:  2007-04-02       Impact factor: 9.306

6.  Presynaptic kynurenate-sensitive receptors inhibit glutamate release.

Authors:  R Carpenedo; A Pittaluga; A Cozzi; S Attucci; A Galli; M Raiteri; F Moroni
Journal:  Eur J Neurosci       Date:  2001-06       Impact factor: 3.386

Review 7.  Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities.

Authors:  Robert Schwarcz; Roberto Pellicciari
Journal:  J Pharmacol Exp Ther       Date:  2002-10       Impact factor: 4.030

8.  Endogenous kynurenic acid disrupts prepulse inhibition.

Authors:  Sophie Erhardt; Lilly Schwieler; Carolina Emanuelsson; Mark Geyer
Journal:  Biol Psychiatry       Date:  2004-08-15       Impact factor: 13.382

9.  Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia.

Authors:  Christine L Miller; Ida C Llenos; Jeanette R Dulay; Meliza M Barillo; Robert H Yolken; Serge Weis
Journal:  Neurobiol Dis       Date:  2004-04       Impact factor: 5.996

Review 10.  Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.

Authors:  Laura F Martin; William R Kem; Robert Freedman
Journal:  Psychopharmacology (Berl)       Date:  2004-02-19       Impact factor: 4.530
View more
  42 in total

1.  Toxoplasma gondii and other risk factors for schizophrenia: an update.

Authors:  E Fuller Torrey; John J Bartko; Robert H Yolken
Journal:  Schizophr Bull       Date:  2012-03-23       Impact factor: 9.306

Review 2.  Translational potential of astrocytes in brain disorders.

Authors:  Alexei Verkhratsky; Luca Steardo; Vladimir Parpura; Vedrana Montana
Journal:  Prog Neurobiol       Date:  2015-09-16       Impact factor: 11.685

Review 3.  Inflammation and the two-hit hypothesis of schizophrenia.

Authors:  Keith A Feigenson; Alex W Kusnecov; Steven M Silverstein
Journal:  Neurosci Biobehav Rev       Date:  2013-11-15       Impact factor: 8.989

Review 4.  Toxoplasma gondii: Biological Parameters of the Connection to Schizophrenia.

Authors:  Jianchun Xiao; Emese Prandovszky; Geetha Kannan; Mikhail V Pletnikov; Faith Dickerson; Emily G Severance; Robert H Yolken
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

5.  Astrogliopathology in neurological, neurodevelopmental and psychiatric disorders.

Authors:  Alexei Verkhratsky; Vladimir Parpura
Journal:  Neurobiol Dis       Date:  2015-04-03       Impact factor: 5.996

6.  Stratification of astrocytes in healthy and diseased brain.

Authors:  Alexei Verkhratsky; Robert Zorec; Vladimir Parpura
Journal:  Brain Pathol       Date:  2017-09       Impact factor: 6.508

Review 7.  Why are astrocytes important?

Authors:  Alexei Verkhratsky; Maiken Nedergaard; Leif Hertz
Journal:  Neurochem Res       Date:  2014-08-12       Impact factor: 3.996

Review 8.  The known and missing links between Toxoplasma gondii and schizophrenia.

Authors:  Hany M Elsheikha; Dietrich Büsselberg; Xing-Quan Zhu
Journal:  Metab Brain Dis       Date:  2016-04-04       Impact factor: 3.584

9.  Neonatal infection with neurotropic influenza A virus induces the kynurenine pathway in early life and disrupts sensorimotor gating in adult Tap1-/- mice.

Authors:  Linnéa Asp; Maria Holtze; Susan B Powell; Håkan Karlsson; Sophie Erhardt
Journal:  Int J Neuropsychopharmacol       Date:  2009-07-17       Impact factor: 5.176

10.  The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex.

Authors:  Hui-Qiu Wu; Edna F R Pereira; John P Bruno; Roberto Pellicciari; Edson X Albuquerque; Robert Schwarcz
Journal:  J Mol Neurosci       Date:  2009-08-19       Impact factor: 3.444
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.